TCF7L1 and prostate cancer: WNT4 located in 1p36 and the induction of WNT4/TCF7L1 resulted in increased malignancy in prostate cancer that was linked to dysregulation of androgen receptor signalling and activation of the IL‐8/CXCR2 pathway.51